Administration [ocac]
Raloxifene [orch, phsu]
Not [ftcn]
Hour [tmco]
Ambulatory [ftcn]
Blood [tisu]
Pressure [phpr]
postmenopausal [tmco]
Women [popg]
Osteopenia [patf]
DOUBLE BLIND [resa]
placebo controlled study [inpr, resa]
Objective [inpr]
Estrogens [horm, phsu, strd]
Decrease [qlco]
postmenopausal [tmco]
Women [popg]
tested [inpr]
Effect [qlco]
Selective Estrogen Receptor Modulator [horm, phsu]
Raloxifene [orch, phsu]
ambulatory blood pressure [fndg]
Study Design [resa]
postmenopausal [tmco]
Women [popg]
Osteopenia [patf]
Health [idcn]
Assigned [ftcn]
DOUBLE BLIND [resa]
Receive [qlco]
placebo [topp]
N NOS [aapp, imft]
Women [popg]
Raloxifene [orch, phsu]
mg/d [qnco]
N NOS [aapp, imft]
Women [popg]
months [tmco]
Blood Pressure [orgf]
Woman [popg]
monitor [hlca]
hours [tmco]
Ambulatory [ftcn]
Device [medd]
Result [ftcn]
Similar [qlco]
placebo [topp]
Outcome [ftcn]
Raloxifene [orch, phsu]
Administration [ocac]
Not [ftcn]
MODIFY [ftcn]
Hour [tmco]
Daytime [tmco]
PM [tmco]
Night time [tmco]
PM [tmco]
Blood Pressure [orgf]
heart rate [clna]
Values [qlco]
day night [tmco]
Hour [tmco]
Rhythmicities [tmco]
Variation [qlco]
Mean blood pressure [fndg]
Evaluated [ftcn]
Analysis [lbpr]
Not [ftcn]
Affected [ftcn]
placebo [topp]
Raloxifene [orch, phsu]
Conclusion [idcn]
Raloxifene [orch, phsu]
Not [ftcn]
postmenopausal [tmco]
Women [popg]
Data [idcn]
Reassuring [hlca]
CARDIOVASCULAR [bdsy]
Safety [hcpp]
Long-term [tmco]
Raloxifene [orch, phsu]
Administration [ocac]
